.png){kind=icon}
.png){kind=icon}
Return
Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition
.png){kind=icon}
OA
AI
A
V
F
K
A
T
C
K
K
A
L
C
H
D
DOI：10.1016/j.jaut.2026.103592.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Palmoplantar pustular psoriasis (PPP) can occur or flare during treatment with IL-17A and IL-17A/F inhibitors • Occurrence of PPP is independent from clinical response in underlying disease domains • Different management strategies may be adopted and point towards heterogeneous and innate immune-driven mechanisms
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7
Papers:
3.1K
Citations:
1.0W
Organization
Cited Papers